# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Jun 18, 2025

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2025-06-18
- Accepted by EDGAR: Jun 18, 2025, 16:12 ET
- Period: 2025-06-13
- Accession: 0001104659-25-060637
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/tm2518262d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/tm2518262d1_8k.htm

Filed Jun 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-060637. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.